BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

597 related articles for article (PubMed ID: 8102932)

  • 1. [3H]-idazoxan binding to rabbit cerebral cortex recognises multiple imidazoline I2-type receptors: pharmacological characterization and relationship to monoamine oxidase.
    Renouard A; Widdowson PS; Cordi A
    Br J Pharmacol; 1993 Jul; 109(3):625-31. PubMed ID: 8102932
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Alpha 2-adrenoceptor subtypes and imidazoline-like binding sites in the rat brain.
    Brown CM; MacKinnon AC; McGrath JC; Spedding M; Kilpatrick AT
    Br J Pharmacol; 1990 Apr; 99(4):803-9. PubMed ID: 1972896
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Discrimination and pharmacological characterization of I2-imidazoline sites with [3H]idazoxan and alpha-2 adrenoceptors with [3H]RX821002 (2-methoxy idazoxan) in the human and rat brains.
    Miralles A; Olmos G; Sastre M; Barturen F; Martin I; Garcia-Sevilla JA
    J Pharmacol Exp Ther; 1993 Mar; 264(3):1187-97. PubMed ID: 8095548
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Species-selective binding of [3H]-idazoxan to alpha 2-adrenoceptors and non-adrenoceptor, imidazoline binding sites in the central nervous system.
    Hussain JF; Kendall DA; Wilson VG
    Br J Pharmacol; 1993 Jul; 109(3):831-7. PubMed ID: 8102937
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Presynaptic imidazoline receptors and non-adrenoceptor [3H]-idazoxan binding sites in human cardiovascular tissues.
    Molderings GJ; Likungu J; Jakschik J; Göthert M
    Br J Pharmacol; 1997 Sep; 122(1):43-50. PubMed ID: 9298527
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Chronic treatment with the monoamine oxidase inhibitors clorgyline and pargyline down-regulates non-adrenoceptor [3H]-idazoxan binding sites in the rat brain.
    Olmos G; Gabilondo AM; Miralles A; Escriba PV; García-Sevilla JA
    Br J Pharmacol; 1993 Mar; 108(3):597-603. PubMed ID: 8385528
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Labelling of I2B-imidazoline receptors by [3H]2-(2-benzofuranyl)-2-imidazoline (2-BFI) in rat brain and liver: characterization, regulation and relation to monoamine oxidase enzymes.
    Alemany R; Olmos G; García-Sevilla JA
    Naunyn Schmiedebergs Arch Pharmacol; 1997 Jul; 356(1):39-47. PubMed ID: 9228188
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The effects of phenelzine and other monoamine oxidase inhibitor antidepressants on brain and liver I2 imidazoline-preferring receptors.
    Alemany R; Olmos G; García-Sevilla JA
    Br J Pharmacol; 1995 Feb; 114(4):837-45. PubMed ID: 7773544
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [3H]2-(2-Benzofuranyl)-2-imidazoline, a highly selective radioligand for I2-imidazoline receptor binding sites. Studies in rabbit kidney membranes.
    Hosseini AR; King PR; Louis WJ; Gundlach AL
    Naunyn Schmiedebergs Arch Pharmacol; 1997 Jan; 355(1):131-8. PubMed ID: 9007853
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Characterization and autoradiographical localization of non-adrenoceptor idazoxan binding sites in the rat brain.
    Mallard NJ; Hudson AL; Nutt DJ
    Br J Pharmacol; 1992 Aug; 106(4):1019-27. PubMed ID: 1356565
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Characterization of binding sites for [3H]-idazoxan, [3H]-P-aminoclonidine and [3H]-rauwolscine in the kidney of the dog.
    Evans RG; Haynes JM
    Clin Exp Pharmacol Physiol; 1994 Aug; 21(8):649-58. PubMed ID: 7813124
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Inhibition of monoamine oxidase A and B activities by imidazol(ine)/guanidine drugs, nature of the interaction and distinction from I2-imidazoline receptors in rat liver.
    Ozaita A; Olmos G; Boronat MA; Lizcano JM; Unzeta M; García-Sevilla JA
    Br J Pharmacol; 1997 Jul; 121(5):901-12. PubMed ID: 9222546
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comparison of the interaction of agmatine and crude methanolic extracts of bovine lung and brain with alpha 2-adrenoceptor binding sites.
    Pinthong D; Hussain JF; Kendall DA; Wilson VG
    Br J Pharmacol; 1995 Jun; 115(4):689-95. PubMed ID: 7582492
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effects of imidazolines on noradrenaline release in brain: an investigation into their relationship to imidazoline, alpha 2 and H3 receptors.
    Schlicker E; Fink K; Kathmann M; Molderings GJ; Göthert M
    Neurochem Int; 1997 Jan; 30(1):73-83. PubMed ID: 9116590
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Binding of [3H]2-(2-benzofuranyl)-2-imidazoline (BFI) to human brain: potentiation by tranylcypromine.
    Wiest SA; Steinberg MI
    Life Sci; 1997; 60(9):605-15. PubMed ID: 9048963
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Inhibition of amine oxidase activity by derivatives that recognize imidazoline I2 sites.
    Carpéné C; Collon P; Remaury A; Cordi A; Hudson A; Nutt D; Lafontan M
    J Pharmacol Exp Ther; 1995 Feb; 272(2):681-8. PubMed ID: 7853182
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [3H]idazoxan binding to bovine adrenal medullary membranes: identification and pharmacological characterization of I2-imidazoline sites.
    Molderings GJ; Kundt L; Göthert M
    Naunyn Schmiedebergs Arch Pharmacol; 1994 Sep; 350(3):252-7. PubMed ID: 7824041
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Opposite age-dependent changes of alpha 2A-adrenoceptors and nonadrenoceptor [3H]idazoxan binding sites (I2-imidazoline sites) in the human brain: strong correlation of I2 with monoamine oxidase-B sites.
    Sastre M; García-Sevilla JA
    J Neurochem; 1993 Sep; 61(3):881-9. PubMed ID: 8395564
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Imidazoline receptors, non-adrenergic idazoxan binding sites and alpha 2-adrenoceptors in the human central nervous system.
    De Vos H; Bricca G; De Keyser J; De Backer JP; Bousquet P; Vauquelin G
    Neuroscience; 1994 Apr; 59(3):589-98. PubMed ID: 8008210
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Selectivity of rilmenidine for I1-imidazoline-binding sites in rabbit proximal tubule cells.
    Gargalidis-Moudanos C; Parini A
    J Cardiovasc Pharmacol; 1995; 26 Suppl 2():S59-62. PubMed ID: 8642808
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 30.